Galectin-9 ameliorates fulminant liver injury

Fulminant hepatitis is a severe liver disease resulting in hepatocyte necrosis. Galectin-9 (Gal-9) is a tandem-repeat-type galectin that has been evaluated as a potential therapeutic agent for various diseases that regulate the host immune system. Concanavalin A (ConA) injection into mice results in...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Med Rep
Auteurs principaux: Tadokoro, Tomoko, Morishita, Asahiro, Sakamoto, Teppei, Fujihara, Shintaro, Fujita, Koji, Mimura, Shima, Oura, Kyoko, Nomura, Takako, Tani, Joji, Yoneyama, Hirohito, Iwama, Hisakazu, Himoto, Takashi, Niki, Toshiro, Hirashima, Mitsuomi, Masaki, Tsutomu
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2017
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482106/
https://ncbi.nlm.nih.gov/pubmed/28534962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.6606
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires